Norstella, a prominent worldwide supplier of AI-driven pharmaceutical intelligence solutions, has introduced the Pipeline-to-Patient Productivity Index. This annual benchmark assesses research and development productivity, market access, and commercial return within the top 25 global biopharmaceutical companies. This index serves as a comprehensive tool for evaluating industry performance.